跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 39,201 条关于
“renin–angiotensin–aldosterone system”
全部
39,201
临床试验
27,866
药物
907
机构
418
资讯
10,010
去年
Alnylam's Zilebesiran Receives MHRA Innovation Passport for Hypertension Treatment
去年
Singapore Trial to Evaluate Multicomponent Intervention for Chronic Kidney Disease Management
去年
Dietary Factors Show Protective Effects Against IgA Nephropathy in Landmark Mendelian Study
去年
Atacicept Shows Sustained eGFR Stabilization in IgAN Patients Over 96 Weeks
去年
Alnylam Advances Heart Drug Zilebesiran to Phase 3 Trial Despite Mid-Stage Statistical Miss
10个月前
AstraZeneca and Sun Pharma Partner to Expand Access to Hyperkalaemia Treatment in India
去年
Atacicept Shows Sustained eGFR Stabilization in IgAN Patients at 96 Weeks in Phase 2b ORIGIN Trial
2年前
Alnylam Advances Zilebesiran to Phase 3 Cardiovascular Outcomes Trial Following Positive KARDIA-3 Results
3个月前
Meta-Analysis Confirms Heart Failure Drugs Protect Cardiac Function During Cancer Therapy
去年
Emerging Therapies Show Promise for Immune Complex Membranoproliferative Glomerulonephritis (IC-MPGN)
第 1 页，共 1001 页
上一页
下一页
